default author photo

Abdelkader El-Hasnaoui

GlaxoSmithKline France

Mr.

100 Route de Versailles

Marly-Le-Roy, 78163

France

SCHOLARLY PAPERS

1

DOWNLOADS

0

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Assessing the Risk of Cervical Cancer Development when Introducing New Prophylactic Management Schemes at Country Level Using a Markov Model: The Case Applied to France

iHEA 2007 6th World Congress: Explorations in Health Economics Paper
Posted: 13 Jun 2007
Bruno Detournay, Abdelkader El-Hasnaoui, Nadia Demarteau and Baudouin Standaert
Cemka-Eval, GlaxoSmithKline France, IMS-Health Belgium and GlaxoSmithKline

Abstract:

Loading...

Risk-assessment, cervical cancer vaccination, Markov models